Yutaka Seino
机构：Kansai Electric Power (Japan), Kansai Electric Power Hospital, Niigata University · ORCID：0000-0002-1099-7989
发表论文 746 篇 · 总被引 31340 次 · h-index 84
代表论文
- Efficacy and safety of the sodium‐glucose co‐transporter‐2 inhibitor empagliflozin in elderly Japanese adults (≥65 years) with type 2 diabetes: A randomized, double‐blind, placebo‐controlled, 52‐week clinical trial ( EMPA‐ELDERLY ) (2023 · Diabetes Obesity and Metabolism · 被引 91)
- Effect of Roxadustat on Thyroid Function in Patients With Renal Anemia (2023 · The Journal of Clinical Endocrinology & Metabolism · 被引 26)
- Gastric inhibitory polypeptide receptor antagonism suppresses intramuscular adipose tissue accumulation and ameliorates sarcopenia (2023 · Journal of Cachexia Sarcopenia and Muscle · 被引 22)
- Effects of luseogliflozin on suspected MASLD in patients with diabetes: a pooled meta-analysis of phase III clinical trials (2024 · Journal of Gastroenterology · 被引 15)
- Differential effects of imeglimin and metformin on insulin and incretin secretion—An exploratory randomized controlled trial (2024 · Diabetes Obesity and Metabolism · 被引 13)
- Empagliflozin is associated with lower cardiovascular risk compared with dipeptidyl peptidase-4 inhibitors in adults with and without cardiovascular disease: EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study results from Europe and Asia (2023 · Cardiovascular Diabetology · 被引 12)